J_and_A_public_Redacted.pdf

This notice announces an indefinite-delivery, indefinite-quantity contract awarded without full and open competition to Palantir Technologies Inc. for $36 million. The justification and approval for sole source award is provided in an attached document. The contract was awarded by the National Institutes of Health National Institute on Drug Abuse on September 27, 2020 under solicitation number 75N95020R00005. The purpose of the contract is to establish a secure scientific platforms environment through Palantir's software and services to support various biomedical and behavioral research projects conducted by the National Center for Advancing Translational Sciences.